TY - JOUR AU - Smith, J. S. AU - Lindsay, L. AU - Hoots, B. AU - Keys, J. AU - Franceschi, S. AU - Winer, R. PY - 2007 DA - 2007// TI - Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22527 DO - 10.1002/ijc.22527 ID - Smith2007 ER - TY - JOUR AU - Sanjose, S. AU - Quint, W. G. AU - Alemany, L. AU - Geraets, D. T. AU - Klaustermeier, J. E. AU - Lloveras, B. PY - 2010 DA - 2010// TI - Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70230-8 DO - 10.1016/S1470-2045(10)70230-8 ID - Sanjose2010 ER - TY - JOUR AU - Kumar, S. AU - Biswas, M. AU - Jose, T. PY - 2015 DA - 2015// TI - HPV vaccine: Current status and future directions JO - Med J Armed Forces India VL - 71 UR - https://doi.org/10.1016/j.mjafi.2015.02.006 DO - 10.1016/j.mjafi.2015.02.006 ID - Kumar2015 ER - TY - JOUR AU - Bahrami, A. A. AU - Ghaemi, A. AU - Tabarraei, A. AU - Sajadian, A. AU - Gorji, A. AU - Soleimanjahi, H. PY - 2014 DA - 2014// TI - DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice JO - J Virol Methods VL - 206 UR - https://doi.org/10.1016/j.jviromet.2014.05.013 DO - 10.1016/j.jviromet.2014.05.013 ID - Bahrami2014 ER - TY - JOUR AU - Tahamtan, A. AU - Ghaemi, A. AU - Gorji, A. AU - Kalhor, H. R. AU - Sajadian, A. AU - Tabarraei, A. PY - 2014 DA - 2014// TI - Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems JO - J Biomed Sci VL - 21 UR - https://doi.org/10.1186/s12929-014-0069-z DO - 10.1186/s12929-014-0069-z ID - Tahamtan2014 ER - TY - JOUR AU - Boyd, D. AU - Hung, C. F. AU - Wu, T. C. PY - 2003 DA - 2003// TI - DNA vaccines for cancer JO - IDrugs VL - 6 ID - Boyd2003 ER - TY - JOUR AU - Saeedi, A. AU - Ghaemi, A. AU - Tabarraei, A. AU - Moradi, A. AU - Gorji, A. AU - Semnani, S. PY - 2014 DA - 2014// TI - Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice JO - Virus Genes VL - 49 UR - https://doi.org/10.1007/s11262-014-1070-z DO - 10.1007/s11262-014-1070-z ID - Saeedi2014 ER - TY - JOUR AU - Lu, S. PY - 2008 DA - 2008// TI - Immunogenicity of DNA vaccines in humans: it takes two to tango JO - Hum Vaccin VL - 4 UR - https://doi.org/10.4161/hv.4.6.6179 DO - 10.4161/hv.4.6.6179 ID - Lu2008 ER - TY - JOUR AU - Chung, Y. AU - Qin, H. AU - Kang, C. Y. AU - Kim, S. AU - Kwak, L. W. AU - Dong, C. PY - 2007 DA - 2007// TI - An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2006-12-061309 DO - 10.1182/blood-2006-12-061309 ID - Chung2007 ER - TY - JOUR AU - Shimizu, K. AU - Kurosawa, Y. AU - Taniguchi, M. AU - Steinman, R. M. AU - Fujii, S. PY - 2007 DA - 2007// TI - Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells JO - J Exp Med VL - 204 UR - https://doi.org/10.1084/jem.20070458 DO - 10.1084/jem.20070458 ID - Shimizu2007 ER - TY - JOUR AU - Banzhoff, A. AU - Gasparini, R. AU - Laghi-Pasini, F. AU - Staniscia, T. AU - Durando, P. AU - Montomoli, E. PY - 2009 DA - 2009// TI - MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0004384 DO - 10.1371/journal.pone.0004384 ID - Banzhoff2009 ER - TY - JOUR AU - Galli, G. AU - Hancock, K. AU - Hoschler, K. AU - DeVos, J. AU - Praus, M. AU - Bardelli, M. PY - 2009 DA - 2009// TI - Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0903181106 DO - 10.1073/pnas.0903181106 ID - Galli2009 ER - TY - JOUR AU - Schwarz, T. F. AU - Horacek, T. AU - Knuf, M. AU - Damman, H. G. AU - Roman, F. AU - Drame, M. PY - 2009 DA - 2009// TI - Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults JO - Vaccine VL - 27 UR - https://doi.org/10.1016/j.vaccine.2009.01.040 DO - 10.1016/j.vaccine.2009.01.040 ID - Schwarz2009 ER - TY - JOUR AU - Takeuchi, O. AU - Akira, S. PY - 2010 DA - 2010// TI - Pattern recognition receptors and inflammation JO - Cell VL - 140 UR - https://doi.org/10.1016/j.cell.2010.01.022 DO - 10.1016/j.cell.2010.01.022 ID - Takeuchi2010 ER - TY - STD TI - Ghaemi A, Sajadian A, Khodaie B, Lotfinia AA, Lotfinia M, Aghabarari A, et al. Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression. Molecular neurobiology. 2016;53(1):143-54. PubMed Epub 2014/11/25. Eng. ID - ref15 ER - TY - JOUR AU - Fraser, C. K. AU - Diener, K. R. AU - Brown, M. P. AU - Hayball, J. D. PY - 2007 DA - 2007// TI - Improving vaccines by incorporating immunological coadjuvants JO - Expert Rev Vaccines VL - 6 UR - https://doi.org/10.1586/14760584.6.4.559 DO - 10.1586/14760584.6.4.559 ID - Fraser2007 ER - TY - JOUR AU - Mancek-Keber, M. AU - Jerala, R. PY - 2015 DA - 2015// TI - Postulates for validating TLR4 agonists JO - Eur J Immunol VL - 45 UR - https://doi.org/10.1002/eji.201444462 DO - 10.1002/eji.201444462 ID - Mancek-Keber2015 ER - TY - JOUR AU - Reed, S. G. AU - Bertholet, S. AU - Coler, R. N. AU - Friede, M. PY - 2009 DA - 2009// TI - New horizons in adjuvants for vaccine development JO - Trends Immunol VL - 30 UR - https://doi.org/10.1016/j.it.2008.09.006 DO - 10.1016/j.it.2008.09.006 ID - Reed2009 ER - TY - JOUR AU - Cluff, C. W. PY - 2010 DA - 2010// TI - Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results JO - Adv Exp Med Biol VL - 667 UR - https://doi.org/10.1007/978-1-4419-1603-7_10 DO - 10.1007/978-1-4419-1603-7_10 ID - Cluff2010 ER - TY - JOUR AU - Garcon, N. AU - Mechelen, M. PY - 2011 DA - 2011// TI - Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems JO - Expert Rev Vaccines VL - 10 UR - https://doi.org/10.1586/erv.11.29 DO - 10.1586/erv.11.29 ID - Garcon2011 ER - TY - JOUR AU - Mattarollo, S. R. AU - West, A. C. AU - Steegh, K. AU - Duret, H. AU - Paget, C. AU - Martin, B. PY - 2012 DA - 2012// TI - NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-04-426643 DO - 10.1182/blood-2012-04-426643 ID - Mattarollo2012 ER - TY - JOUR AU - Motohashi, S. AU - Nagato, K. AU - Kunii, N. AU - Yamamoto, H. AU - Yamasaki, K. AU - Okita, K. PY - 2009 DA - 2009// TI - A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0800126 DO - 10.4049/jimmunol.0800126 ID - Motohashi2009 ER - TY - JOUR AU - Burdin, N. AU - Brossay, L. AU - Koezuka, Y. AU - Smiley, S. T. AU - Grusby, M. J. AU - Gui, M. PY - 1998 DA - 1998// TI - Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes JO - J Immunol VL - 161 ID - Burdin1998 ER - TY - JOUR AU - Nagaraj, S. AU - Ziske, C. AU - Strehl, J. AU - Messmer, D. AU - Sauerbruch, T. AU - Schmidt-Wolf, I. G. PY - 2006 DA - 2006// TI - Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo JO - Int Immunol VL - 18 UR - https://doi.org/10.1093/intimm/dxl059 DO - 10.1093/intimm/dxl059 ID - Nagaraj2006 ER - TY - JOUR AU - Ghaemi, A. AU - Soleimanjahi, H. AU - Gill, P. AU - Hassan, Z. M. AU - Razeghi, S. AU - Fazeli, M. PY - 2011 DA - 2011// TI - Protection of mice by a lambda-based therapeutic vaccine against cancer associated with human papillomavirus type 16 JO - Intervirology VL - 54 UR - https://doi.org/10.1159/000320197 DO - 10.1159/000320197 ID - Ghaemi2011 ER - TY - JOUR AU - Fujii, S. AU - Shimizu, K. AU - Smith, C. AU - Bonifaz, L. AU - Steinman, R. M. PY - 2003 DA - 2003// TI - Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20030324 DO - 10.1084/jem.20030324 ID - Fujii2003 ER - TY - JOUR AU - Kaer, L. AU - Parekh, V. V. AU - Wu, L. PY - 2013 DA - 2013// TI - Invariant natural killer T cells as sensors and managers of inflammation JO - Trends Immunol VL - 34 UR - https://doi.org/10.1016/j.it.2012.08.009 DO - 10.1016/j.it.2012.08.009 ID - Kaer2013 ER - TY - JOUR AU - Kim, D. AU - Hung, C. F. AU - Wu, T. C. AU - Park, Y. M. PY - 2010 DA - 2010// TI - DNA vaccine with alpha-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells JO - Vaccine VL - 28 UR - https://doi.org/10.1016/j.vaccine.2010.08.079 DO - 10.1016/j.vaccine.2010.08.079 ID - Kim2010 ER - TY - JOUR AU - Huang, Y. AU - Chen, A. AU - Li, X. AU - Chen, Z. AU - Zhang, W. AU - Song, Y. PY - 2008 DA - 2008// TI - Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2008.02.002 DO - 10.1016/j.vaccine.2008.02.002 ID - Huang2008 ER - TY - JOUR AU - Guillonneau, C. AU - Mintern, J. D. AU - Hubert, F. X. AU - Hurt, A. C. AU - Besra, G. S. AU - Porcelli, S. PY - 2009 DA - 2009// TI - Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0813309106 DO - 10.1073/pnas.0813309106 ID - Guillonneau2009 ER - TY - JOUR AU - Shimizu, K. AU - Goto, A. AU - Fukui, M. AU - Taniguchi, M. AU - Fujii, S. PY - 2007 DA - 2007// TI - Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.5.2853 DO - 10.4049/jimmunol.178.5.2853 ID - Shimizu2007 ER - TY - JOUR AU - Youn, H. J. AU - Ko, S. Y. AU - Lee, K. A. AU - Ko, H. J. AU - Lee, Y. S. AU - Fujihashi, K. PY - 2007 DA - 2007// TI - A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.04.081 DO - 10.1016/j.vaccine.2007.04.081 ID - Youn2007 ER - TY - JOUR AU - Silk, J. D. AU - Hermans, I. F. AU - Gileadi, U. AU - Chong, T. W. AU - Shepherd, D. AU - Salio, M. PY - 2004 DA - 2004// TI - Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy JO - J Clin Invest VL - 114 UR - https://doi.org/10.1172/JCI200422046 DO - 10.1172/JCI200422046 ID - Silk2004 ER - TY - JOUR AU - Choi, Y. S. AU - Hoory, T. AU - Monie, A. AU - Wu, A. AU - Connolly, D. AU - Hung, C. F. PY - 2008 DA - 2008// TI - alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2008.08.027 DO - 10.1016/j.vaccine.2008.08.027 ID - Choi2008 ER - TY - JOUR AU - Mutwiri, G. AU - Drunen Littel-van den Hurk, S. AU - Gerdts, V. AU - Auray, G. AU - Eng, N. AU - Garlapati, S. PY - 2011 DA - 2011// TI - Combination adjuvants: the next generation of adjuvants? JO - Expert Rev Vaccines VL - 10 UR - https://doi.org/10.1586/erv.10.154 DO - 10.1586/erv.10.154 ID - Mutwiri2011 ER - TY - JOUR AU - Hermans, I. F. AU - Silk, J. D. AU - Gileadi, U. AU - Masri, S. H. AU - Shepherd, D. AU - Farrand, K. J. PY - 2007 DA - 2007// TI - Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.5.2721 DO - 10.4049/jimmunol.178.5.2721 ID - Hermans2007 ER - TY - JOUR AU - Choi, I. K. AU - Lee, J. S. AU - Zhang, S. N. AU - Park, J. AU - Sonn, C. H. AU - Lee, K. M. PY - 2011 DA - 2011// TI - Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rbeta2 or IL-18Ralpha JO - Gene Ther VL - 18 UR - https://doi.org/10.1038/gt.2011.37 DO - 10.1038/gt.2011.37 ID - Choi2011 ER - TY - JOUR AU - Wang, J. AU - Kobayashi, Y. AU - Sato, A. AU - Kobayashi, E. AU - Murakami, T. PY - 2004 DA - 2004// TI - Synergistic anti-tumor effect by combinatorial gene-gun therapy using IL-23 and IL-18 cDNA JO - J Dermatol Sci VL - 36 UR - https://doi.org/10.1016/j.jdermsci.2004.08.001 DO - 10.1016/j.jdermsci.2004.08.001 ID - Wang2004 ER - TY - JOUR AU - Buferne, M. AU - Chasson, L. AU - Grange, M. AU - Mas, A. AU - Arnoux, F. AU - Bertuzzi, M. PY - 2015 DA - 2015// TI - IFNgamma producing CD8 T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas JO - Oncoimmunology VL - 4 UR - https://doi.org/10.4161/2162402X.2014.974959 DO - 10.4161/2162402X.2014.974959 ID - Buferne2015 ER -